ChexFract: Specialized Vision-Language Models for Fracture Detection in Chest X-rays
This repository contains the pre-trained models from our paper "ChexFract: From General to Specialized - Enhancing Fracture Description Generation in Medical AI".
📋 Overview
ChexFract models are specialized vision-language models fine-tuned for accurate fracture detection and description in chest X-ray images. These models significantly outperform general-purpose radiology report generation systems on fracture-specific tasks.
🏆 Model Performance
Released Models
We release two best-performing models, each optimized for their respective encoder architecture:
ChexFract-MAIRA-2 (Best F1-Score with MAIRA-2 encoder)
Configuration: Templated text + Fine-tuned encoder (unfrozen)
ROC-AUC: 0.713
F1-Score: 0.629
Accuracy: 0.748
Precision: 0.682
Recall: 0.584
ChexFract-CheXagent (Best F1-Score with CheXagent encoder)
Configuration: Templated text + Fine-tuned encoder (unfrozen)
Training: Fine-tuned encoder (unfrozen) + templated text on ChexFract dataset
⚠️ Limitations and Clinical Use
Important: These models are designed for research purposes. They are NOT intended for standalone diagnostic use.
📝 Citation
If you use these models in your research, please cite:
bibtex
1@article{chexfract2025,
2 title={ChexFract: From General to Specialized - Enhancing Fracture Description Generation in Medical AI},
3 author={Nechaev, Nikolay and Przhezdzetskaia, Evgeniia and Umerenkov, Dmitry and Dylov, Dmitry V.},
4 journal={arXiv preprint arXiv:XXXX.XXXXX},
5 year={2025},
6 institution={Artificial Intelligence Research Institute (AIRI)}
7}
📄 License
Model License
Important: These models are derivative works based on multiple pre-trained models. The license for these models is subject to the most restrictive terms among the base model licenses.
Effective License: These models are provided under terms compatible with the most restrictive license among the base model licenses. Users must comply with ALL applicable base model licenses.
Base Model Licenses:
Rad-DINO encoder (from MAIRA-2): Microsoft Research License Agreement (MSRLA) - see microsoft/rad-dino-maira-2 for full terms
CheXagent-2-3b encoder: Creative Commons Attribution Non Commercial 4.0 (CC-BY-NC-4.0) - see StanfordAIMI/CheXagent-2-3b for full terms
CheXagent-2-3b uses CC-BY-NC-4.0, which PROHIBITS commercial use without explicit permission
Rad-DINO (MAIRA-2) uses MSRLA, which typically has restrictions on commercial use without permission
Phi-3.5 uses MIT License, which allows commercial use
The most restrictive license applies: These models are NOT licensed for commercial use due to CC-BY-NC-4.0 and MSRLA restrictions. For commercial use, you must obtain appropriate licenses from the original model owners.
Before using these models, you must:
Review the license terms of all base models in their original repositories
Ensure your use case complies with all applicable licenses (especially for commercial purposes)
Include appropriate attribution and copyright notices as required by each license
Obtain commercial licenses if needed from model owners (Microsoft for MAIRA-2, Stanford for CheXagent)
Additional License Information
The fine-tuning code and modifications specific to this work may be subject to additional licensing terms. Please review all applicable licenses before commercial use.
👥 Authors
Nikolay Nechaev - Artificial Intelligence Research Institute (AIRI)
Evgeniia Przhezdzetskaia - Artificial Intelligence Research Institute (AIRI)
Dmitry Umerenkov - Artificial Intelligence Research Institute (AIRI)
Dmitry V. Dylov - Artificial Intelligence Research Institute (AIRI)
We thank the contributors to the MIMIC-CXR, PadChest, BIMCV-COVID19, CheXpert, and OpenI datasets for making their data publicly available. We also acknowledge the computational resources provided for this research.
Institution: Artificial Intelligence Research Institute (AIRI), Moscow, Russia
Disclaimer: These models are provided for research purposes only. They are not intended for clinical use without proper validation and regulatory approval.